Defecetive Drugs: adrugrecall.com
NEWS®
- Accutane®
- Advair®
- Avandia®
- Bextra®
- Botox®
- Byetta®
- CellCept®
- Chantix®
- Cipro®
- Crestor®
- Digitek®
- Duragesic Patch®
- Fleet Phospho Soda®
- Floxin®
- Fluoroquinolone
- Fosamax®
- Gardasil®
- Heparin®
- Hydroxycut®
- Levaquin®
- MRI Dye
- Neurontin®
- Noroxin®
- Nuvaring®
- Ortho Evra®
- Paxil®
- Permax®
- PTU
- Raptiva®
- Reglan®
- Risperdal®
- Serevent®
- Seroquel®
- Trasylol®
- Viagra®
- Vioxx®
- Yasmin®
- Zelnorm®
- Zicam®
- Zyprexa®
Zyprexa lawsuit on behalf of Canadians filed
February 5, 2005
Eli Lilly and Co. is the target of another proposed Zyprexa class action lawsuit in Canada.
The Zyprexa lawsuit is similar to another Canadian lawsuit filed last month. The Indianapolis, Indiana based drugmaker is being sued for damages of $900 million on behalf of all Canadians who took Zyprexa and became diabetic.
Zyprexa is approved as a schizophrenia and bipolar disorder drug and is Lilly's best selling drug. The company also faces Zyprexa related lawsuits in the United States.For more information on Zyprexa side effects and lawsuit information, please contact us.
More Recent Defective Drug News
Contact an News Attorney Near You
Use this form to request a free consultation with a qualified attorney near you.
- Popular Drug Recalls: Avandia®
- Yaz® Birth Control
- NuvaRing®
- Reglan®
- Home
- Drug Index
- News Archive
- Resources